Regulus Therapeutics Inc
NASDAQ:RGLS
Income Statement
Earnings Waterfall
Regulus Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-31.1m
USD
|
Operating Income
|
-31.1m
USD
|
Other Expenses
|
1.1m
USD
|
Net Income
|
-30m
USD
|
Income Statement
Regulus Therapeutics Inc
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||||||||||||||||||||||
Revenue |
20
N/A
|
18
-8%
|
14
-22%
|
9
-36%
|
8
-14%
|
10
+34%
|
13
+30%
|
14
+6%
|
21
+47%
|
17
-18%
|
14
-20%
|
12
-12%
|
1
-90%
|
1
-39%
|
0
-64%
|
0
-69%
|
0
-13%
|
0
+14%
|
0
N/A
|
0
N/A
|
0
-13%
|
7
+9 671%
|
7
N/A
|
7
N/A
|
7
0%
|
0
-99%
|
0
-29%
|
5
+9 960%
|
10
+99%
|
10
0%
|
10
N/A
|
5
-50%
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | ||||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(37)
|
(41)
|
(45)
|
(49)
|
(53)
|
(57)
|
(69)
|
(71)
|
(76)
|
(80)
|
(77)
|
(81)
|
(83)
|
(81)
|
(80)
|
(76)
|
(70)
|
(66)
|
(58)
|
(53)
|
(47)
|
(41)
|
(32)
|
(27)
|
(24)
|
(20)
|
(22)
|
(23)
|
(24)
|
(24)
|
(25)
|
(27)
|
(28)
|
(29)
|
(29)
|
(28)
|
(28)
|
(29)
|
(29)
|
(30)
|
(31)
|
|
Selling, General & Administrative |
(7)
|
(8)
|
(9)
|
(10)
|
(12)
|
(12)
|
(15)
|
(17)
|
(19)
|
(21)
|
(18)
|
(19)
|
(18)
|
(17)
|
(21)
|
(19)
|
(17)
|
(17)
|
(13)
|
(13)
|
(13)
|
(13)
|
(12)
|
(12)
|
(11)
|
(10)
|
(10)
|
(9)
|
(9)
|
(9)
|
(9)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(10)
|
(9)
|
(9)
|
(10)
|
(10)
|
|
Research & Development |
(30)
|
(33)
|
(36)
|
(39)
|
(41)
|
(45)
|
(53)
|
(54)
|
(56)
|
(60)
|
(59)
|
(62)
|
(64)
|
(63)
|
(60)
|
(58)
|
(53)
|
(49)
|
(45)
|
(39)
|
(34)
|
(28)
|
(20)
|
(15)
|
(12)
|
(9)
|
(11)
|
(13)
|
(15)
|
(15)
|
(15)
|
(17)
|
(17)
|
(18)
|
(19)
|
(18)
|
(18)
|
(20)
|
(20)
|
(20)
|
(21)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
Operating Income |
(18)
N/A
|
(23)
-29%
|
(31)
-36%
|
(40)
-28%
|
(45)
-12%
|
(47)
-5%
|
(55)
-17%
|
(57)
-3%
|
(55)
+4%
|
(63)
-16%
|
(63)
0%
|
(69)
-9%
|
(82)
-18%
|
(80)
+2%
|
(80)
0%
|
(76)
+5%
|
(70)
+8%
|
(66)
+6%
|
(58)
+12%
|
(52)
+10%
|
(47)
+11%
|
(34)
+27%
|
(25)
+26%
|
(20)
+19%
|
(17)
+17%
|
(20)
-17%
|
(21)
-9%
|
(18)
+18%
|
(14)
+19%
|
(14)
-2%
|
(15)
-1%
|
(22)
-50%
|
(28)
-27%
|
(29)
-3%
|
(29)
-2%
|
(28)
+3%
|
(28)
+0%
|
(29)
-3%
|
(29)
0%
|
(30)
-2%
|
(31)
-5%
|
|
Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
(0)
|
(1)
|
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(0)
|
(0)
|
0
|
0
|
(1)
|
(0)
|
(0)
|
0
|
1
|
1
|
1
|
|
Non-Reccuring Items |
(1)
|
(2)
|
2
|
3
|
(12)
|
(12)
|
(13)
|
(15)
|
(2)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Pre-Tax Income |
(19)
N/A
|
(24)
-29%
|
(29)
-19%
|
(36)
-26%
|
(57)
-55%
|
(58)
-3%
|
(68)
-16%
|
(71)
-5%
|
(56)
+21%
|
(62)
-12%
|
(63)
0%
|
(69)
-10%
|
(82)
-19%
|
(81)
+1%
|
(81)
-1%
|
(78)
+5%
|
(72)
+7%
|
(68)
+6%
|
(60)
+12%
|
(55)
+9%
|
(49)
+11%
|
(36)
+26%
|
(27)
+25%
|
(22)
+18%
|
(19)
+16%
|
(21)
-14%
|
(23)
-9%
|
(19)
+17%
|
(16)
+19%
|
(16)
0%
|
(15)
+6%
|
(22)
-48%
|
(28)
-26%
|
(29)
-3%
|
(30)
-4%
|
(29)
+4%
|
(28)
+1%
|
(29)
-2%
|
(29)
+1%
|
(29)
-1%
|
(30)
-4%
|
|
Net Income | ||||||||||||||||||||||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
36
|
36
|
36
|
36
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
|
Income from Continuing Operations |
(19)
|
(24)
|
(29)
|
(36)
|
(57)
|
(58)
|
(68)
|
(71)
|
(56)
|
(62)
|
(63)
|
(69)
|
(82)
|
(81)
|
(81)
|
(77)
|
(36)
|
(32)
|
(24)
|
(18)
|
(49)
|
(36)
|
(27)
|
(22)
|
(19)
|
(21)
|
(23)
|
(19)
|
(16)
|
(16)
|
(15)
|
(22)
|
(28)
|
(29)
|
(30)
|
(29)
|
(28)
|
(29)
|
(29)
|
(29)
|
(30)
|
|
Net Income (Common) |
(19)
N/A
|
(24)
-30%
|
(29)
-19%
|
(36)
-27%
|
(57)
-56%
|
(58)
-3%
|
(68)
-16%
|
(71)
-5%
|
(56)
+21%
|
(62)
-12%
|
(63)
0%
|
(69)
-10%
|
(82)
-19%
|
(81)
+1%
|
(81)
-1%
|
(77)
+5%
|
(72)
+7%
|
(68)
+6%
|
(60)
+11%
|
(55)
+9%
|
(49)
+11%
|
(36)
+26%
|
(27)
+25%
|
(22)
+18%
|
(19)
+16%
|
(21)
-14%
|
(23)
-9%
|
(19)
+17%
|
(16)
+18%
|
(16)
0%
|
(15)
+6%
|
(22)
-48%
|
(28)
-26%
|
(29)
-3%
|
(30)
-4%
|
(29)
+4%
|
(28)
+1%
|
(29)
-2%
|
(29)
+1%
|
(29)
-1%
|
(30)
-4%
|
|
EPS (Diluted) |
-53.34
N/A
|
-67.16
-26%
|
-80
-19%
|
-101.22
-27%
|
-153.18
-51%
|
-139.11
+9%
|
-156.97
-13%
|
-164.41
-5%
|
-129.65
+21%
|
-142
-10%
|
-142.11
0%
|
-156.93
-10%
|
-186
-19%
|
-183.29
+1%
|
-184.47
-1%
|
-103.3
+44%
|
-114.14
-10%
|
-78.06
+32%
|
-69.14
+11%
|
-62.75
+9%
|
-55.98
+11%
|
-34.55
+38%
|
-16.23
+53%
|
-10.7
+34%
|
-10.74
0%
|
-8.82
+18%
|
-7.78
+12%
|
-5.06
+35%
|
-4.5
+11%
|
-2.21
+51%
|
-1.92
+13%
|
-2.52
-31%
|
-3.24
-29%
|
-1.95
+40%
|
-2.03
-4%
|
-1.91
+6%
|
-1.86
+3%
|
-1.7
+9%
|
-1.49
+12%
|
-1.46
+2%
|
-1.58
-8%
|